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Invasive nontyphoidal Salmonella (NTS), including Salmonella typhi-
murium (STm), are major yet poorly-recognized killers of infants in
sub-Saharan Africa. Death in these children is usually associated with
bacteremia, commonly in the absence of gastrointestinal symptoms.
Evidence from humans and animal studies suggest that severe infec-
tion and bacteremia occur when specific Ab is lacking. Understanding
how Ab responses to Salmonella are regulated will help develop
vaccines against these devastating infections. STm induces atypical
Ab responses characterized by prominent, accelerated, extrafollicular
T-independent (TI) Ab against a range of surface antigens. These
responses develop without concomitant germinal centers, which only
appear as infection resolves. Here, we show STm rapidly induces a
population of TI B220CD5 B1b cells during infection and TI Ab from
B1b cells targets the outer membrane protein (Omp) porins OmpC,
OmpD and OmpF but not flagellin. When porins are used as immu-
nogens they can ablate bacteremia and provide equivalent protection
against STm as killed bacterial vaccine and this is wholly B cell-
dependent. Furthermore Ab from porin-immunized chimeras, that
have B1b cells, is sufficient to impair infection. Infecting with porin-
deficient bacteria identifies OmpD, a protein absent from Salmonella
Typhi, as a key target of Ab in these infections. This work broadens
the recognized repertoire of TI protein antigens and highlights the
importance of Ab from different B cell subsets in controlling STm
infection. OmpD is a strong candidate vaccine target and may, in part,
explain the lack of cross-protection between Salmonella Typhi and
STm infections.
B cells  vaccines
Infections caused by nontyphoidal strains of Salmonella (NTS;primarily the serovars Typhimurium and Enteritidis) have a
staggering impact on human health in infants and HIV adults,
particularly in sub-Saharan Africa. In HIV infants, the burden
of NTS is greatest between 6 mo and 3 years and gastrointestinal
symptoms are apparent in50% of cases indicating NTS disease
in Africa may be different to that in the West. Bacteremia is a
strong correlate of disease severity and mortality in bacteremic
children who reach clinic can be nearly 25%. Thus, restricting
bacteremia may be pivotal to control these infections (1, 2).
The requirements for effective immunity to Salmonella de-
pend on the stage of infection. Effective clearance of primary
infection requires persistent Th1 T cell responses, whereas at this
stage Ab limits bacteremia (3, 4). It is significant that although
individuals who lack components of the IL-12 or IL-23 signaling
pathways are more susceptible to invasive NTS disease they can
still generate serum anti-Salmonella IgG (5). Furthermore, these
children do not die from NTS infection, are frequently without
bacteremia, and do not commonly appear with chronic NTS
infection within their first 2 years of life (6).
The peak risk of disseminated NTS infection of between 6 and
24 mo supports a role for Ab against NTS because this coincides
with loss of maternal Ab but before active humoral immunity is
acquired (7). Because vaccination of adults with isolated cap-
sular polysaccharide (a wholly TI antigen), induces protective
serum IgG against typhoid but poor mucosal responses (8), it
implies that serum Ab is sufficient to protect against typhoid and
so may protect against NTS too.
We recently reported that STm induces an atypical Ab re-
sponse with rapid and massive extrafollicular plasma cell re-
sponses decoupled from parallel induction of germinal centers
(4). The induction of this response is not T cell mediated
although switching to the Th1 isotype IgG2a is T-dependent.
Our studies identified STm Omp as early targets of switched Ab
in this response. These contain many proteins including the
related porins OmpC, OmpD, and OmpF, which are of a similar
Mr (40 kDa). OmpR regulates OmpC and OmpF expression
but not OmpD (9). Salmonella Typhi (ST) lack OmpD although
it is found in all other Salmonella serovars examined (10).
Purified porins from ST induce an atypically long-lived Ab
response, which contrasts to the gradually declining responses
frequently observed after immunization with alum-precipitated
proteins (11).
Here, we show that porins and live STm induce B1b cells in a
TI manner, whereas flagellin does not. A single immunization
with porins from STm, but not ST, could moderate infection with
virulent and attenuated STm. Ab to OmpD was important
because porin immunization did moderate infection with bac-
teria lacking OmpC and OmpF but not bacteria lacking OmpD.
Therefore, protein antigens from STm can induce TI antibodies
via B1b cells and OmpD may be a candidate for a subunit vaccine
against systemic NTS infection. We suggest that Ab-mediated
vaccines, although unlikely to result in sterilizing immunity, can
restrict the devastating impact of NTS infections.
Results
Salmonella Induce a Rapid TI Plasma Cell Response Against Selective
Antigens. Previous studies show that Salmonella induces a rapid and
extensive Ab response (4). Major targets of the early, switched
Author contributions: K.T.J., C.D.B., I.C.M.M., and A.F.C. designed research; C.G.-C., S.B.,
J.L.M., E.A.R., R.E.C., M.K., K.T.J., and A.F.C. performed research; C.G.-C., R.A.K., I.R.H.,
D.L.L., G.D., and C.L.-M. contributed new reagents/analytic tools; C.G.-C., S.B., J.L.M.,
I.C.M.M., and A.F.C. analyzed data; and I.C.M.M. and A.F.C. wrote the paper.
Conflict of interest statement: The results of this work have led to OmpD being patented
as potential vaccine candidate against selected Salmonella infections.
This article is a PNAS Direct Submission.
1G.G.-C., S.B., and J.L.M. contributed equally to this work.
2To whom correspondence should be addressed. E-mail: a.f.cunningham@bham.ac.uk.
www.pnas.orgcgidoi10.1073pnas.0812431106 PNAS  June 16, 2009  vol. 106  no. 24  9803–9808
IM
M
U
N
O
LO
G
Y
response are Omp but not LPS or the flagellar protein, FliC. The
rapid induction of this response suggested a TI element. To dissect
this further, we infected mice lacking all T cells (TCR-deficient
mice) with attenuated STm. Infection resulted in a large increase in
CD138 plasmacytoid cells by day 4 paralleled by a rapid induction
of STm-specific serum IgM (Fig. 1A). Detailed analysis revealed a
strong induction of Ab to LPS and Omp, but a less marked response
to FliC (Fig. 1A). We focused on the TI response to Omp by
examining the response to a highly pure porin preparation from
STm containing OmpC and OmpD and some OmpF (Fig. 1B and
Materials and Methods). Analyses (Fig. 1B) showed that purified
porins, predominantly formed -strands, were heat-modifiable
consistent with folded porins, and were oligomeric with oligomers
typically 120–240 kDa thus suggesting a trimeric or hexameric
configuration. Therefore, the porins adopt a natively folded oligo-
meric state consistent with their normal conformation in the outer
membrane. ELISA and immunoblotting of sera from immunized T
cell-deficient mice indicated that porins induced antigen-specific
IgM (Fig. 1C). In contrast anti-porin Ab was only a minor com-
ponent of the natural Ab pool, because nonimmune sera (at 1:50)
reacted with nonporin but not porin proteins. Thus, IgM Ab was
induced specifically to STm porins in the absence of T cell help.
Porin-Induced Impairment of STm Infection Is Mediated Through B
Cells. It was then assessed whether Ab to purified porins could
impair STm infection. WT mice were immunized with porins or
heat-killed bacteria [HK, an established vaccine (8)] and challenged
35 days later. Both immunogens conferred comparable benefit,
reducing splenic bacterial burdens by 2–3 logs (Fig. 2A). To assess
the role of B cells WT mice and B cell-deficient mice (IgH/mice)
were immunized with porins and infected after 35 days. Immunized
B cell-deficient mice had similar bacterial numbers as nonimmu-
nized mice (Fig. 2B). In contrast, opsonization of bacteria with
complement-inactivated sera from porin-immunized T cell-
deficient mice reduced infection in these mice. Because the effects
of porin immunization were B cell-mediated and TI we assessed
whether switched Ab conferred additional benefit over IgM. To test
this WT, CD28-deficient and T cell-deficient mice were immunized
with porins and infected 35 days later. Although porin-specific IgM
was induced in all groups after infection (Fig. 2C), porin-specific
IgG was largely undetectable in T cell-deficient mice. Bacterial
burdens were 10-fold greater in CD28-deficient animals and 40-fold
greater in T cell-deficient mice. Because porin immunization was
only effective in the presence of B cells and all groups of naı¨ve
animals had similar bacterial numbers 5 days after infection these
data suggest that90% of the benefit was IgG mediated (Fig. 2C).
Because bacteremia is a marker of severity the blood bacterial
burden of nonimmunized and porin immunized animals was as-
sessed. On day 5 of infection in nonporin-primed mice the median
bacteremia was 6.0 103 bacteria/mL whereas after immunization
no bacteria were detected in blood (Fig. 2D). Thus, porin immu-
nization is effective at eliminating bacteremia.
We next assessed how anti-porin Ab moderates infection to
virulent STm strain SL1344. A single porin-immunization reduced
splenic and liver bacterial numbers 4 days after infection by 20- and
40-fold respectively; a second porin immunization reduced this by
1,700- and 400-fold respectively (Fig. 2E). In these experiments, the
reduction in bacterial numbers after porin immunization may
prolong survival but would not prevent death. Last, we examined
whether LPS from STm or porins from ST could provide similar
benefits. Mice were immunized with highly pure STm LPS or with
ST porins and infected 35 days later. Neither pure LPS nor ST
porins conferred any benefit (Fig. 2F). This was surprising consid-
ering the high degree of identity between OmpC and OmpF from
these 2 serovars. This suggests responses to the third STm porin,
OmpD, may be important during NTS infection.
Ab to OmpD Is Sufficient to Impair STm Infection. It was then tested
whether Ab to OmpD could account for the differing results
observed after immunization with STm or ST porins. Mice were
immunized with porins and infected with either STm or STm
lacking OmpD. Bacterial numbers were similar in the spleen and
livers of naı¨ve and immunized mice after infection with OmpD-
deficient STm but immunization offered significant protection
against bacteraemia (Fig. 3A). This impaired protection corre-
lated with IgM Ab from porin-immunized mice failing to bind to
the porin fraction from OmpD-deficient STm (Fig. 3A). In
contrast after porin immunization and infection with OmpR-
deficient bacteria (lacking OmpC and OmpF but not OmpD)
bacterial numbers were reduced, bacteremia was not measurable
and binding of IgM Ab from porin-immunized mice to the porin
fraction from OmpR-deficient STm was evident (Fig. 3B). This
indicates that OmpD is an important target of Ab to STm and
Ab to OmpD alone is sufficient to impair STm infection.
Porins and STm Induce a Population of Peritoneal B Cells with a B1b
Phenotype. The results above show the effectiveness of porin
immunization depends on B cells and these responses are
induced in the absence of T cells. Thus, we assessed whether TI
B1 cells were recruited against porins. WT mice were immunized
and peritoneal responses assessed 4 days later, using 7 color flow
cytometry. CD19 and IgM lymphocytes were gated for low/
negative CD21 and CD23 expression and these examined for
CD5 and B220 expression. Finally, CD11b expression on the
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Fig. 1. Porins from STm induce a T-independent Ab response. (A) T cell-
deficient TCR/ mice were infected i.p. with 5 105 attenuated STm for 4
days, and splenic CD138 plasmacytoid cells per square millimeter (Left) were
assessed by immunohistology. Anti-STm, anti-LPS, anti-flagellin (FliC), and
anti-total Omp serum IgM was assessed by ELISA (Right). Data are represen-
tative of 2 experiments. (B) Analysis of porin purity and structure. Electro-
phoretic separation of porins showing their purity (Left) reveals 2 major
species OmpC and OmpD with trace amounts of OmpF (see Materials and
Methods). (Center) A spectrum of porins, using CD [millidegrees (mdeg)],
indicating they are -stranded. The boxed gel (Right) shows the electro-
phoretic pattern of porins under denaturing (100 °C) or seminative (25 °C)
conditions. (Lower Left) s distributions (c(s)) for porins after AUC, indicating
that the porins had a peak coefficient indicative of oligomeric structures with
Mr of 120–240 kDa. (C) ELISA assessment of porin-specific IgM from nonim-
munized and 7-day (d) porin-immunized TCR/ mice. Immunoblot of IgM
binding to Omp from naı¨ve and porin-immunized mice. Porins separate to the
boxed area. Binding of sera to other proteins (such as 27 kDa) reflects the
presence of natural Ab and is independent of porin immunization. ELISA data
representative of 3 experiments; immunoblots of 5 naı¨ve and immune sera.
The Mann–Whitney test was applied to compare the statistical significance
between groups linked by bars. NI, noninfected. *, P  0.05.
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B220CD5 population was assessed. Porin immunized mice,
compared with nonimmunized mice, showed a significant in-
duction of B cells with characteristics of B1b cells, being CD19
and IgM, B220int but CD5 with low CD21 and CD23 expres-
sion (Fig. 4A). B1b cells were also significantly induced by live
STm and purified LPS but not HK STm, FliC, or OVA (Fig. 4A,
OVA, and data not shown). CD11b expression was variable
between the groups. CD11b B1b cells have been reported
previously, at similar proportions to those described here, and
have the potential to become CD11b after transfer into lym-
phopenic recipients (12). The T-independence of this B1b
induction was shown by giving porins or STm to TCR-
deficient mice (Fig. 4B). These experiments showed a significant
induction of B1b cells but also confirmed the differential ex-
pression of CD11b on B1b cells induced by porins or STm. Thus,
STm and porins induce a peritoneal population of TI B1b B cells.
Anti-Porin Ab from B1b B Cells Is Sufficient to Impair Infection. To test
whether Ab produced by B1b cells responding to porins could
limit STm infection chimeric mice were generated that have B1b
cells but lack B1a cells and have few B2 cells (13). Peritoneal
B220CD5 cells were sorted from 4 day porin-immunized WT
mice and 2  105 sorted cells were transferred into B cell-
deficient mice (Fig. 5A). This population does include B2
follicular cells but these cells do not expand after transfer into
lymphopenic mice (14) and thus only contribute a small pro-
portion of the final B cell population after B1b cell expansion.
Nonimmunized B1b chimeras could produce natural IgM anti-
body but this did not react to porins (Fig. 5A). Forty-eight hours
after cell transfer B1b recipients and B cell-deficient mice that
did not receive cells were immunized with porins. After 20 days
the success of immunization was confirmed by measuring anti-
porin IgM from the immunized chimeras. The next day mice
were infected with 5 105 STm and bacterial burdens and serum
Ab assessed 5 days later. Only mice that had peritoneal B cells
and anti-porin Ab could impair STm infection (Fig. 5B). Porin-
immunized B cell-deficient mice that did not receive B1b cells
had bacterial numbers equivalent to nonimmunized mice. After
infection peritoneal B cells in B1b chimeras were IgM, and
approximately half were also CD11b (Fig. 5B). Therefore, Ab
from B1b cells is sufficient to limit infection.
Discussion
This work has 3 major findings: First, Ab to OmpD can reduce
STm infection. Second, porins and viable STm but not FliC,
induce a TI B1b cell response. Finally porin-induced Ab from
these cells impairs STm infection. There has been controversy
about the role of LPS in responses to porins, in part because LPS
may associate with some porin trimers (e.g., OmpF). In the
current study LPS was unlikely to be a potential confounder
because purified porins had low levels of LPS and immunization
with highly pure STm LPS did not moderate infection (Fig. 2F).
Furthermore, infecting porin-immunized mice with LPS-
sufficient, OmpD-deficient STm resulted in a diminution in Ab
binding to the cell wall and a failure to reduce bacterial infection.
OmpD is a trimeric porin with homology to OmpF and OmpC
(9, 15) whose expression is enhanced by anaerobiosis and
suppressed by low pH, whereas OmpF and OmpC expression is
sensitive to changes in osmolarity (16). OmpD has an unclear
role in infection whereas loss of OmpR is attenuating (17, 18).
Studies have identified a lack of cross-reactivity between surface
binding mAb to these 3 porins (19). Indeed, for OmpD many
antibodies only recognize the protein in trimeric but not mono-
meric form (19) suggesting exposed regions are under selective
immune pressure. Multiple studies have assessed the potential of
porins as vaccines, often with conflicting results, but few have
specifically examined OmpD, presumably because of its absence
in ST (e.g., ref. 20). Some studies that failed to show benefit from
porins involved passive transfer of anti-porin antibodies (e.g. ref.
21), which may not have sufficiently covered the porin epitope
repertoire. The current study shows that the natural response to
OmpD in STm is sufficient to achieve marked reductions in
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bacterial numbers, although its effects may be potentiated by
other factors, such as natural antibody. The importance of
antibody to OmpD does not preclude roles for antibody to OmpF
or OmpC, because other reasons may account for its minor role
here, such as the amount of OmpF and OmpC in the prepara-
tions, or their expression in STm at different growth stages.
The failure to achieve sterile immunity after porin immuni-
zation may not be an impediment to reducing disease; for in
humans multiple lines of evidence suggest sterilizing immunity is
not essential to achieve clinical benefit. In infants in sub-Saharan
Africa systemic STm infection can lead to fatal bacteremia (2).
The peak incidence of this, between 6 and 24 months, coincides
with the loss of passively acquired maternal IgG and before
protection from active immunity. Nearly all children have Ab by
3 years, indicating previous exposure, indeed Ab correlates with
decreased risk of bacteremia (7). Similarly, some patients with
defective IL-12/23 signaling lacking a clinical history of Salmo-
nella infection have anti-Salmonella IgG (5). This suggests
IL-12/23-independent mechanisms may exist for coping with
NTS infections. Therefore, the sterilizing immunity necessary to
protect against infection with virulent STm SL1344 in suscep-
tible strains of mice may overstate the degree of immunity
required to protect against NTS or typhoid in humans. Indeed in
vaccinated humans the protection vaccines confer can be over-
whelmed if the infecting dose is sufficiently high (22). Thus,
although it is unlikely Ab can confer sterilizing immunity it can
diminish bacterial numbers at the time of infection and the
extracellular dissemination of infection that results in bactere-
mia. Therefore, even modest reductions in infecting NTS num-
bers may result in substantial clinical benefits.
TI Ab to protein antigens has been described for the glyco-
protein of vesicular stomatitis virus (23) and complement factor
H-binding protein from the bacterial pathogen Borrelia (24). For
the latter, self-renewing B1b cells play important roles (25) as
they do in pneumococcal infections (26). This suggests B1b cells
may play significant roles in a range of infections and reflects our
ever increasing understanding of the diversity of B cell responses
to pathogens (27). In the current study all benefits from porin
immunization were B cell mediated and Ab from B1b cells was
sufficient to impair infection (Figs. 2B and 5). The induction of
B1b cells to porins and STm may also explain, at least in part, why
the early nonswitched extrafollicular plasma cell response occurs
similarly in WT and T cell-deficient/impaired mice whereas
functional T cell responses are required for extrafollicular re-
sponses against model protein antigens (28). The massive extent
and rapid induction of the extrafollicular Ab response to STm
suggests antigen availability is not limiting (4) and the B1b cell
repertoire may be broader than originally thought.
Responses to typhoid Vi antigen may involve B1b cells and so
immunization with STm porins or Vi antigen may act similarly
in their respective infections. However, Ab to purified Vi antigen
in humans is wholly TI and induces poor mucosal Ab (8) but
porins can induce good T-dependent responses (29). It has long
been appreciated that infants and the elderly have impaired
responses to TI-2 antigens, such as capsular polysaccharide. It is
tempting to speculate, as others have, that deficiencies in B1b
cells in children are responsible for susceptibility to encapsulated
bacteria (30). Interestingly, whereas responses to TI-2 antigens
involve 2 sets of B cells, B1b cells, and marginal zone (MZ) B
cells, mice deficient in the tyrosine kinase pyk2 lack MZ but not
B1b B cells yet induce potent IgM and IgG responses to the TI-2
antigen TNP-Ficoll (31). In addition, RAG-1 mice reconstituted
with as few as 105 B1b cells and lacking other B cell types mount
strong and persistent Ab responses to NP-Ficoll (13). This
suggests that responses to TI antigens are likely to be of sufficient
evolutionary importance that multiple cell types are involved.
Materials and Methods
Mice, Bacterial Strains, Immunogens, and Biophysical Assessments. Animal
studies had ethical and Home Office approval. WT and gene-deficient mice are
reportedelsewhereexceptforTCR/mice,whichwerefromJax(4).Micewere
age (6–12 weeks) and sex-matched. STm SL1344 is a virulent strain and SL3261 is
an AroA attenuated strain (described in ref. 4). OmpD STm strain RAK126 was
made by transferring the Tn10::tetr insertion in ompD of STm strain BRD455 (17,
18) by P22 generalized transduction into SL3261. The OmpR STm strain RAK83
was constructed using red recombinase (32). Briefly, aph, encoding kanamycin
resistance, was amplified using primers (5GGATCGTCTGCTGACCCGTGAATCTT-
TCCATCTCATGGGTGTAGGCTGGAGCTGCTTC3 and 5GTCTGAATATAACGCG-
GATGTGCCGGATCTTCTTCCACATTCCGGGGATCCGTCGACC3) that contained se-
quence flanking the deletion target and electrotransformed into STm SL3261
expressing-redrecombinase.TheompR::aphwastransferredtoSTmSL3261by
P22 transduction. The genotype of strains was confirmed by PCR and PAGE.
Total Omp preparations were made by 2% (vol/vol) Triton X-100 extraction
(4). Purified porins from ST (strain ATCC 9993) and STm (strain ATCC 14028)
were generated (29) by repeated extraction with SDS and separation by FPLC on
a Sephacryl S-200 column before dialysis against PBS/0.1% (wt/vol) SDS. Limulus
amebocyte lysate assay showed LPS contamination at 0.06 EU/480 g porins.
Protein identity was confirmed by trypsin digest and mass spectrometry. TLR-
grade STm LPS was purchased (Axxora ALX-581-011-L002). Flagellin was made as
described in ref. 4. OVA, Imject grade, was from Thermo Scientific.
For sedimentation velocity and CD measurements protein was dialyzed
against PBS, 0.1% SDS, pH 7.4, at 20 °C. Far UV CD measurements were
performed on a Jasco J-715 spectropolarimeter with a 1-mm path length cell,
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Fig. 3. OmpD is an important target of the humoral immune response to
STm. (A) Nonimmunized (NI) or porin-immunized WT mice were infected with
5  106 STm (closed circles) or 5  106 STm lacking OmpD (STmOmpD strain
RAK126; open circles) for 5 days and splenic, liver and blood bacterial numbers
enumerated (representative of 3 experiments for spleen and liver). Immuno-
blot analysis of IgM from NI or porin-immunized TCR/ mice against cell
walls from STm or STm lacking OmpD. The boxed region shows the approxi-
mate Mr of the porins OmpC and F. (B) NI or porin-immunized WT mice were
infected with 5 106 STm 5 106 STm cells (filled circles) or 5 106 STm cells
lacking OmpR (STmOmpR strain RAK83) (open circles) for 5 days and splenic,
liver, and blood bacterial numbers enumerated (representative of 2 experi-
ments). Immunoblot analysis of IgM from NI or porin-immunized TCR/
mice against cell walls from STm or STm lacking OmpR. The boxed region
shows the approximate Mr of the porin OmpD. The Mann–Whitney test was
applied to compare the statistical significance between groups linked by bars.
*, P  0.05; NS, not significant; d, day.
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2-nm bandwidth, 1-nm increments, 100 nm/min scanning speed, 2-s response
time, and continuous scanning mode. 20 scans were averaged and the spec-
trum corrected for buffer contribution. Data were interpreted using standard
methods described in ref. 33.
Analytical ultracentrifugation (AUC) sedimentation velocity was per-
formed in a Beckman Coulter proteome XL-I protein characterization system.
Protein and buffer reference were centrifuged at 20,000 rpm in a Ti-50 rotor
and analyzed using Sedfit (34).
Immunization and Infection of Mice and Opsonization Experiments. Mice were
immunized i.p. with 20 g of proteins or LPS in PBS for 35 days unless stated
otherwise. HK bacteria (107 per mouse) were heated for 1 h at 65 °C. Bacteria
were from cultures with an OD600 of 1.0. Mice were infected i.p. with
attenuated bacteria at 5 105 or 5 106 per animal as described in the text.
Mice were infected i.p. with 3  103 WT SL1344 bacteria. Bacterial numbers
were determined by direct culturing (4). Experiments with mice and opsonized
bacteria were performed as described previously except sera were from naı¨ve
or immunized TCR/ mice (4). A single serum was used per mouse and all
sera were heat-inactivated at 56 °C for 0.5 h. Bacteria (2.5 106/mL) and sera
(1:100) were mixed for 0.5 h before infection and bacterial viability and lack
of agglutination confirmed.
Immunohistology, ELISA, and Immunoblotting. Immunohistology was per-
formed on frozen sections as described in ref. 4. CD138 cells were detected
using rat anti-mouse CD138 (BD), biotinylated sheep anti-rat and streptavidin-
ABComplex alkaline phosphatase (AP) (DakoCytomation) (4). Cells per square
millimeter were calculated using a point-counting technique (35). ELISA was
performed as previously described to detect Ab to STm, LPS, FliC, and OMP (4).
Antigen was used at 5 g/mL and primary antibodies and AP-linked goat
anti-mouse isotype antibodies used to identify isotypes. To detect serum IgM
posttransfer, wells were coated with Rat anti-mouse IgM and bound IgM
detected as above. For immunoblotting, proteins were transferred onto PVDF
membrane and endogenous HRP eliminated using SG substrate (Vector Lab-
oratories). Sera were added overnight (1:50 for naı¨ve and 1:100 500 for
immunized sera) and signal detected with HRP-conjugated goat anti-mouse
IgM and Supersignal Chemiluminescense (Thermo Scientific).
FACS Analysis and Cell Sorting. Cells were stained with one or more of these
anti-mouse mAb: IgMFITC (eB121–15F9), IgMPE-Cy7 (11/41), CD19APC-Cy7 (1D3),
CD3 PerCPcy5 (145–2C11), CD11c APC (N418), CD11b PE (M1/70), CD5 PE-Cy5
(53–7.3 or Ly-1), B220APC (RA3–6B2) or B220Pacific Blue (RA3–6B2), CD21FITC
(7G6), and CD23PE (B3B4) (All from E-Bioscience) and assessed on a FACScalibur
or CyAn ADP Flow Cytometer and analyzed using FlowJo 8.8.3. (TreeStar). B1b
chimeras were generated as described in ref. 13, with modifications. WT mice
were immunized with porins for 4 days and B1b cells (B220int CD5) sorted. Cells
(2 105) were transferred into IgH/mice and 3 days later chimeras immunized
i.p. with 20 g of porins. Transfer success was confirmed by detecting IgM and
anti-porin Ab 20 days later before challenge with STm.
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Statistics. Statistics were calculated using the Mann–Whitney test; significance
was accepted at P  0.05 (4).
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